Cargando…

The efficacy and safety of high-dose nonsedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials

BACKGROUND: Standard doses of second-generation H(1)-antihistamines (sgAHs) as first-line treatment are not always effective in treating chronic spontaneous urticaria (CSU), and hence an increase in the dose of sgAHs is recommended. However, literature evaluating the efficacy and safety of this trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Xianjun, Xue, Peiwen, Shi, Yunzhou, Yao, Junpeng, Cao, Wei, Zhang, Leixiao, Zou, Zihao, Zhou, Siyuan, Wang, Chuan, Chen, Mingling, Jin, Rongjiang, Li, Ying, Zheng, Qianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080829/ https://www.ncbi.nlm.nih.gov/pubmed/37024900 http://dx.doi.org/10.1186/s40360-023-00665-y

Ejemplares similares

Compound glycyrrhizin combined with antihistamines for chronic urticaria: A protocol for systematic review and meta analysis
por: Cao, Wei, et al.
Publicado: (2020)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

Cupping for patients with chronic urticaria: A systematic review protocol
por: Xiao, Xianjun, et al.
Publicado: (2019)

Efficacy of acupuncture treatment for chronic spontaneous urticaria: study protocol for a randomised controlled trial
por: Zheng, Qianhua, et al.
Publicado: (2022)

Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties
por: Kawauchi, Hideyuki, et al.
Publicado: (2019)

Functional connectivity impairment of thalamus-cerebellum-scratching neural circuits in pruritus of chronic spontaneous urticaria
por: Zhang, Leixiao, et al.
Publicado: (2022)

Antihistaminic, Anti-Inflammatory, and Antiallergic Properties of the Nonsedating Second-Generation Antihistamine Desloratadine: A Review of the Evidence
por: Canonica, G. Walter, et al.
Publicado: (2011)

Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic Urticaria
por: Godse, Kiran, et al.
Publicado: (2016)

Efficacy and safety of acupuncture for patients with chronic urticaria: study protocol of a randomized, sham-controlled pilot trial
por: Shi, Yunzhou, et al.
Publicado: (2019)

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017)

Systematic reviews of pharmacological and nonpharmacological treatments for patients with chronic urticaria: An umbrella systematic review
por: Shi, Yunzhou, et al.
Publicado: (2019)

Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol
por: Zhang, Leixiao, et al.
Publicado: (2019)

Acupoint injection of Bacillus Calmette–Guerin polysaccharide nucleic acid for patients with chronic urticaria: A protocol for systematic review
por: Cao, Wei, et al.
Publicado: (2020)

Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria
por: van den Elzen, Mignon T., et al.
Publicado: (2017)

Autologous Whole Blood Injection for the Treatment of Antihistamine-Resistant Chronic Spontaneous Urticaria
por: You, Hyang-Suk, et al.
Publicado: (2015)

Features of Antihistamine-Resistant Chronic Urticaria and Chronic Urticaria During Exacerbation
por: Huilan, Zhu, et al.
Publicado: (2015)

Effects of bepotastine, a nonsedating H1-antihistamine, for the treatment of persistent cough and allergic rhinitis: a randomised, double-blind, placebo-controlled trial
por: Lee, Ji-Hyang, et al.
Publicado: (2023)

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
por: Kim, Mi-Ae, et al.
Publicado: (2023)

Bepotastine-induced urticaria, cross-reactive with other antihistamines
por: Kang, Ju Wan, et al.
Publicado: (2016)

The role of short-chain fatty acids in inflammatory skin diseases
por: Xiao, Xianjun, et al.
Publicado: (2023)

H(1)-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study
por: Weller, Karsten, et al.
Publicado: (2011)

Fenebrutinib in H(1) antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
por: Metz, Martin, et al.
Publicado: (2021)

Altered Gut Microbiota in H1-Antihistamine-Resistant Chronic Spontaneous Urticaria Associates With Systemic Inflammation
por: Song, Yao, et al.
Publicado: (2022)

High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
por: Madsen, Hanne, et al.
Publicado: (2021)

Drug eruption by antihistamine mistaken for chronic urticaria in a child
por: Lee, Gun Moo, et al.
Publicado: (2019)

Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients
por: Mann, Caroline, et al.
Publicado: (2022)

Acupuncture for patients with chronic pruritus: protocol of a systematic review and meta-analysis
por: Zhang, Leixiao, et al.
Publicado: (2020)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

Association of Patients' Characteristics with Acupuncture Treatment Outcomes in Treating Bell's Palsy: Results from a Randomised Controlled Trial
por: Xiao, Xianjun, et al.
Publicado: (2019)

Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study
por: Ulambayar, Bastsetseg, et al.
Publicado: (2019)

Variations of Thiol–Disulfide Homeostasis Parameters after Treatment with H1-Antihistamines in Patients with Chronic Spontaneous Urticaria
por: Matei, Clara, et al.
Publicado: (2021)

Up-dosing of non-sedating antihistamines in chronic urticaria: Need for well-designed clinical trials in India
por: Patil, Anant D.
Publicado: (2014)

Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
Publicado: (2022)

Autologous Serum Therapy in Chronic Urticaria: A Promising Complement to Antihistamines
por: Debbarman, Panchami, et al.
Publicado: (2014)

Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria
por: Sánchez-Borges, Mario, et al.
Publicado: (2014)

Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia
por: Recto, Marysia Tiongco, et al.
Publicado: (2017)

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H(1) Antihistamines: A Randomized, Placebo-Controlled Study
por: Saini, Sarbjit S, et al.
Publicado: (2015)

The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria
por: Choi, Jeong-Hee, et al.
Publicado: (2020)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Autologous serum therapy reduces the symptoms and antihistamine burden in patients with chronic urticaria
por: Mohammed, Jinan Q.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p9dm4osl2bpdb9gtl009pll3sp